Skip to content

News Blog / Research

FDA approves Phase IIa clinical trials of L-serine

U.S. Food and Drug Administration (FDA) logo

See links to the FDA-approved Phase IIa clinical trial of L-serine for ALS patients, and the FDA-approved Phase IIa clinical trial of L-serine for early stage Alzheimer's patients.

More newsAll news